Nanomaterials for Wound Healing: Mechanisms and Challenges

Diabetes, old age, infections, and malnutrition are some of the causes of chronic wounds, which are a major global health problem. These wounds affect millions of people and put an elevated demand on the health systems worldwide. Traditional wound dressings are often incapable of counteracting the main pathological features of chronic wounds, which include continuous biofilm formation, prolonged inflammation, and deficient tissue regeneration. The primary aim of this review is to outline the growing pharmaceutical potential of nanomaterials in the management of advanced and chronic wounds. Specifically, this work evaluates how nanotechnology improves healing through advanced drug delivery systems and antibacterial agents, and it proposes new hybrid solutions such as combining nanomaterials with bioactive scaffolds and 3D bioprinted dressings to shift wound care toward precise, responsive treatments for hard-to-heal injuries. This includes examining how the structural dimensionality of these nanomaterials, categorized into zero-dimensional nanoparticles, one-dimensional electrospun nanofibers, and two-dimensional graphene oxide-based composites, enhances their therapeutic efficacy. These nanomaterials provide benefits such as a large surface area, high biocompatibility, the ability to regulate drug release, and the capability to perform multiple functions. Thus, they make it possible to treat different pathological conditions of wounds by means of antibacterial, anti-inflammatory, and pro-regenerative activities. There is an increasing focus on plant-derived nanomaterials for their antioxidant capabilities as well as for their potential for largescale, environmentally friendly manufacturing. The results from animal studies and small clinical trials indicate that nanomaterial-based dressings can, in some cases, speed up wound healing compared to traditional methods, although the efficacy differs among wound types and experimental models. Moving forward, the principal focus in this area of wound nanomedicine is on personalization, where microbiome analysis, inflammatory biomarker tracking, and wound sensor devices will help to continuously adapt the therapeutic materials. New techniques for production, such as microfluidic nanoparticle creation and AI-aided toxicology testing, combined with flexible clinical trial protocols, are expected to overcome the issues of safety testing, production at scale, and clinical application.